The mechanisms underlying the NAD+-induced decrease in tumor cell survival include increased oxidative stress and opening of P2X7 receptors, because both antioxidants and P2X7 receptor antagonists can prevent the NAD+-induced decrease in tumor cell survival [27]. Here, P2RX7 is linked to neoplasm.